Why now is the appropriate time to get into the cannabis commerce
CNBC’s Melissa Lee sits down with ‘The Trade’ to talk about why traders thinks appropriate now is a appropriate time to get into cannabis.
The organization ‘Natty Approaches to Marijuana’ wants America to rethink legalizing cannabis
Kevin Sabet, president and CEO of Natty Approaches to Marijuana, an organization leading the lobbying effort against legalization of the drug, joins “Explain Box” to point to why his organization…
Phillip Morris CEO: It be untimely to affirm the firm will enter the cannabis industry
Philip Morris Global André Calantzopoulos joins ‘Closing Bell’ to discuss concerning the regulation of nicotine, how the firm’s duty-free gross sales had been impacted by the pandemic and whether or…
Tilray CEO: Opportunities in medical cannabis are huge
Tilray’s stock is up this present day, nonetheless serene down 80 percent from a February excessive. CNBC’s Frank Holland reports on his conversation with Tilray CEO Irwin Simon about the…
Cannabis stocks are flying high on the path to legalization
Pot stocks wing greater on legalization hopes. With CNBC’s Julia Boorstin and Melissa Lee, and and the Immediate Money traders, Guy Adami, Tim Seymour, Steve Grasso and James McDonald. For…
Cannabis is one in every of the fastest rising industry in the U.S.
April 20 marks the unofficial vacation for marijuana and prison gross sales are expected to reach $24 billion this year. CNBC’s Frank Holland experiences. For win admission to to are…
Green Thumb CEO on cannabis explain: Consumer question is high
CNBC’s “Verbalize on the Road” group discusses pot stock ETFs and sector explain with Green Thumb Industries CEO Ben Kovler.
The sights and sounds from the cannabis conference in Las Vegas
MJBizCon, the cannabis trade’s largest and oldest trade conference, goes on in Las Vegas. With CNBC’s Melissa Lee and the Immediate Money merchants, Carter Value, Courtney Garcia, Guy Adami and…
Crackdown on Canadian cannabis imports
Florida Ranking. Matt Gaetz discusses why he thinks imports of Canadian cannabis for U.S. scientific trials is developing wealth in Canada as an different of the U.S.